Pre-clinical murine models show that Tregs are important for establishing metastatic sites following dissemination of tumor cells, highlighting in particular the role of receptor activator of nuclear factor kappa-B ligand (RANKL) on Tregs in directly promoting RANK+ breast cancer invasion [120]. This evidence concerns the gene TNFSF11 and neoplasm.